Table 1.
Characteristics of subjects enrolled.
| Childhood asthmatics† (n = 32) | Adult asthmatics‡ (n = 17) | |
|---|---|---|
| Gender, male (%) | 23 (71.9) | 6 (35.3) |
| Age, year | 8.63 (1.93) | 60.11 (11.71) |
| Smoking, yes (%) | Not applicable | 3 (17.65) |
| Body mass index, kg/m2 | 17.71 (3.21) | 23.72 (5.18) |
| Vitamin D, ng/mL | 31.81 (9.97) | 14.71 (7.72) |
| Tanner stage (%) | ||
| I/II/III/IV/V | 24 (75.0)/6 (18.8)/1(3.1)/1 (3.1) | Not applicable |
| Baseline BMD Z-score | −0.10 (2.23) | Not available |
| Ethnicity (%) | ||
| Non-Hispanic white | 32 (100) | 0 |
| Asian | 0 | 17 (100) |
| Cumulative dose of PD, mg | 1188.40 (608.05) | 3130.53 (1552.09) |
| Final BMD Z-score | −0.29 (0.81) | −0.97 (1.37) |
Data indicate mean (Standard deviation); BMD, Bone mineral density; PD, Prednisone; †Characteristics measured at enrollment of the CAMP study except cumulative dose of prednisone and the final BMD Z-score; ‡Characteristics measured at enrollment of the present study.